Related Experiment Video
Updated: Jul 9, 2026
10:10
Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography
Published on: July 29, 2011
London after Tomlinson. Clinical research
1British Postgraduate Medical Federation, University of London.
BMJ (Clinical Research Ed.)
|October 31, 1992
Summary
Sir Bernard Tomlinson's report on London health services impacts UK clinical research. The article proposes a research market for patient costs to sustain clinical research and ensure excellence.
Area of Science:
- Health services research
- Clinical research policy
- Health economics
Background:
- Sir Bernard Tomlinson's report addresses London's health services.
- Proposals in the report have significant implications for clinical research nationwide.
- There is a perceived decline in UK research and development, impacting clinical research.
Purpose of the Study:
- To examine the implications of Tomlinson's proposals on clinical research.
- To evaluate related strategies for sustaining clinical research.
- To recommend a novel market-based approach for clinical research funding.
Main Methods:
- Analysis of Tomlinson's report and its strategic context.
- Examination of existing market mechanisms in the National Health Service (NHS).
- Development of a proposal for a research market for patient costs in clinical research.
Main Results:
- Tomlinson's proposals necessitate a broader consideration of clinical research infrastructure.
- Existing NHS market structures for patient services can be complemented.
- A dedicated market for patient costs in clinical research is identified as a viable strategy.
Conclusions:
- Implementing a research market for patient costs can support the UK's clinical research base.
- This market-based approach can help guarantee the excellence of clinical research.
- The strategy aims to sustain and enhance clinical research capabilities within the UK.
Related Concept Videos
01:18Interdisciplinary Care: The Health Care Team-II
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...